Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion

Infusion of allogeneic NK cells is a potential immunotherapy for both hematopoietic malignancies and solid tumors. Interactions between killer immunoglobulin-like receptors (KIR) on human NK cells and KIR-ligands on tumor cells influence the magnitude of NK function. To obtain sufficient numbers of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Wang, Wei, Erbe, Amy K., Alderson, Kory A., Phillips, Emily, Gallenberger, Mikayla, Gan, Jacek, Campana, Dario, Hank, Jacquelyn A., Sondel, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477646/
https://ncbi.nlm.nih.gov/pubmed/27392940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-016-1864-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados